| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |



From the Department of Pathology and Immunology,* University of Geneva, Geneva, Switzerland; the Department of Pathology,
University of Bern, Bern, Switzerland; and the Laboratoire du Bacillus Calmette-Guerin and Unité de Physiopathologie de lInfection,
Institut Pasteur, Paris, France
To study the specific role of transmembrane tumor necrosis factor (TmTNF) in host defense mechanisms against bacillus Calmette-Guerin (BCG) and Mycobacterium tuberculosis infections, we compared the immune responses of TNF/lymphotoxin (LT)-
/ mice expressing a noncleavable transgenic TmTNF (TmTNF tg) to those of TNF/LT-
/ and wild-type mice. Susceptibility of TNF/LT-
/ mice to BCG infection was associated with impaired induction of systemic RANTES but not of monocyte chemoattractant protein 1 (MCP-1), the development of excessive local and systemic Th1-type immune responses, and a substantially reduced inducible nitric oxide synthase (iNOS) activity. Resistance of TmTNF tg mice to BCG infection was associated with efficient activation of iNOS in granulomas and with the regulated release of local and systemic chemokines and Th1-type cytokines. However, M. tuberculosis infection of TmTNF tg mice resulted in longer survival and enhanced resistance compared to TNF/LT-
/ mice but higher sensitivity than wild-type mice. TmTNF tg mice exhibited reduced pulmonary iNOS expression and showed an exacerbated cellular infiltration in the lungs despite a modest bacillary content. Our data thus indicate a role for TmTNF in host defense against mycobacteria by contributing to induction and regulation of Th1-type cytokine and chemokine expression leading to development of bactericidal granulomas expressing iNOS, which critically determines susceptibility versus resistance of the host to mycobacterial infections.
This article has been cited by other articles:
![]() |
S. C. Cowley, J. D. Sedgwick, and K. L. Elkins Differential Requirements by CD4+ and CD8+ T Cells for Soluble and Membrane TNF in Control of Francisella tularensis Live Vaccine Strain Intramacrophage Growth J. Immunol., December 1, 2007; 179(11): 7709 - 7719. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zalevsky, T. Secher, S. A. Ezhevsky, L. Janot, P. M. Steed, C. O'Brien, A. Eivazi, J. Kung, D.-H. T. Nguyen, S. K. Doberstein, et al. Dominant-Negative Inhibitors of Soluble TNF Attenuate Experimental Arthritis without Suppressing Innate Immunity to Infection J. Immunol., August 1, 2007; 179(3): 1872 - 1883. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Uchiyama, I. Kawamura, T. Fujimura, M. Kawanishi, K. Tsuchiya, T. Tominaga, T. Kaku, Y. Fukasawa, S. Sakai, T. Nomura, et al. Involvement of Caspase-9 in the Inhibition of Necrosis of RAW 264 Cells Infected with Mycobacterium tuberculosis Infect. Immun., June 1, 2007; 75(6): 2894 - 2902. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Spohn, R. Guler, P. Johansen, I. Keller, M. Jacobs, M. Beck, F. Rohner, M. Bauer, K. Dietmeier, T. M. Kundig, et al. A Virus-Like Particle-Based Vaccine Selectively Targeting Soluble TNF-{alpha} Protects from Arthritis without Inducing Reactivation of Latent Tuberculosis J. Immunol., June 1, 2007; 178(11): 7450 - 7457. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. O'Kane, J. J. Boyle, D. E. Horncastle, P. T. Elkington, and J. S. Friedland Monocyte-Dependent Fibroblast CXCL8 Secretion Occurs in Tuberculosis and Limits Survival of Mycobacteria within Macrophages J. Immunol., March 15, 2007; 178(6): 3767 - 3776. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. McCoy, T. N. Martinez, K. A. Ruhn, D. E. Szymkowski, C. G. Smith, B. R. Botterman, K. E. Tansey, and M. G. Tansey Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. J. Neurosci., September 13, 2006; 26(37): 9365 - 9375. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Musicki, H. Briscoe, S. Tran, W. J. Britton, and B. M. Saunders Differential Requirements for Soluble and Transmembrane Tumor Necrosis Factor in the Immunological Control of Primary and Secondary Listeria monocytogenes Infection. Infect. Immun., June 1, 2006; 74(6): 3180 - 3189. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Torres, L. Janot, V. F.J. Quesniaux, S. I. Grivennikov, I. Maillet, J. D. Sedgwick, B. Ryffel, and F. Erard Membrane Tumor Necrosis Factor Confers Partial Protection to Listeria Infection Am. J. Pathol., December 1, 2005; 167(6): 1677 - 1687. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |